BloggingStocks has a new home! Daily Finance.

Click here to visit the new home of BloggingStocks!

Hot on DailyFinance:

See More Stories

delcath posts

Feed

Delcath jumps 18% as its chemotherapy agent gets orphan drug status

Posted Aug 31st 2009 5:30PM by Melly Alazraki (RSS feed)
Filed under: Press Releases, Products and Services

Delcath Systems Inc. (NASDAQ: DCTH), which in pre-market trading shot up 48%, closed the trading session up 18% to close at $3.60 after the FDA granted its chemotherapy agent doxorubicin, used primarily for live cancer an orphan drug status. The Orphan Drug Act was created to encourage and promote research for therapies of rare conditions and diseases that affect less than 200,000 a year in the United States.

Continue reading Delcath jumps 18% as its chemotherapy agent gets orphan drug status

Symbol Lookup
IndexesChangePrice
DJIA+72.8112,874.04
NASDAQ+27.512,931.39
S&P 500+9.131,351.77

Last updated: February 13, 2012: 04:25 PM

Hot Stocks

General Electric

19.045+0.17(+0.90)

Alcoa

10.315+0.025(+0.24)

Apple Inc

502.45+9.03(+1.83)

Google Inc 'A'

611.86+5.95(+0.98)

Bank of America

8.255+0.185(+2.29)

Wal-Mart Stores

61.765-0.135(-0.22)

Exxon Mobil Corp

84.395+0.595(+0.71)

Ford

12.535+0.095(+0.76)

Citigroup

32.89-0.035(-0.11)

IBM

192.49+0.07(+0.04)

Yahoo

16.105-0.035(-0.22)

Starbucks

49.235+0.415(+0.85)

Microsoft

30.555+0.06(+0.20)

Home Depot

45.935+0.605(+1.33)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

  • My Portfolio
  • Create a New Portfolio

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1329168345779 ms.